Glaxo: Good show - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

StockSelect
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Glaxo: Good show

Apr 23, 2004

India's largest pharma company in terms of market share, GlaxoSmithKline pharmaceuticals has declared its 1QFY05 results. The net sales of the company are up 21% in the first quarter, while the net profit of the company is up 43% on the back of better operating efficiency. The operating margin of the company has increased to 25% from 19% levels in the same quarter last year.

(Rs m) 1QFY04 1QFY05 Change
Net sales 2,589 3,123 20.6%
Other income 95 136 43.3%
Expenditure 2,114 2,368 12.0%
Operating profit (EBDITA) 474 754 59.0%
Operating profit margin (%) 18.3% 24.2%  
Depreciation 44 40 -8.5%
Profit before tax 526 851 61.8%
Extraordinary items 25 (32) -
Tax 200 317 58.5%
Profit after tax/(loss) 351 502 43.0%
Net profit margin (%) 13.6% 16.1%  
No. of shares (m) 74.7 74.7  
Diluted earnings per share (Rs)* 18.8 26.9  
P/E ratio (x)   25.7  
(* annualised)      

To Read the Full Story, Subscribe or Sign In
To Read the Full Story, Subscribe or Sign In


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Sep 25, 2020 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - VENUS REMEDIES COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS